GlobeNewswire

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso

Share

Metso Corporation, Stock exchange release on August 1, 2019, at 10:00 a.m. EET


Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso


Metso Corporation has received a notification, pursuant to Chapter 9, Section 5 and 6 of the Finnish Securities Markets Act, about a change in the holding of mutual funds managed by BlackRock, Inc. of the total amount of shares and financial instruments entitling to shares of Metso.

On July 30, 2019, BlackRock, Inc.'s direct holding in Metso shares and voting rights fell below 5 percent threshold. Blackrock, Inc. had 7,378,406 shares or 4.90 percent of total shares and votes. Its holding through financial instruments amounted to 249,517 shares, which corresponds to 0.16 percent of the total amount of Metso’s shares. On July 30, 2019, BlackRock, Inc.'s total position in Metso amounted to 7,627,923 or 5.07 percent of Metso’s shares and votes. Metso’s total number of shares and votes is 150,348,256.


BlackRock, Inc.’s holdings according to the notification:

  % of shares and voting rights (A) % of shares and voting rights through financial instruments (B) Total of both in %
(A + B)
Resulting situation on the date on which the threshold was reached 4.90% 0.16% 5.07%
Position of previous notification 5.01% 0.17% 5.19%


A: Shares and voting rights
  Number of shares and voting rights % of shares and voting rights
ISIN Code Direct

(SMA 9:5)
Indirect

(SMA 9:6 and 7)
Direct

(SMA 9:5)
Indirect

(SMA 9:6 and 7)
FI0009007835   7,378,406   4.90%
SUBTOTAL A 7,378,406 4.90%
 
B: Financial Instruments according to SMA 9:6a
Type of financial instrument Expiration date Exercise Period Physical of cash settlement Number of shares and voting rights % of shares and voting rights
Securities Lent N/A N/A N/A N/A N/A
CFD N/A N/A Cash 249,517 0.16%
      SUBTOTAL B 249,517 0.16%

                                  
Metso Corporation

Distribution:
Nasdaq Helsinki
Media
www.metso.com

Metso is a world-leading industrial company offering equipment and services for the sustainable processing and flow of natural resources in the mining, aggregates, recycling and process industries. With our unique knowledge and innovative solutions, we help our customers improve their operational efficiency, reduce risks and increase profitability. Metso is listed on the Nasdaq Helsinki in Finland and had sales of about EUR 3.2 billion in 2018. Metso employs over 14,000 people in more than 50 countries.

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

ACTIVE BIOTECH UPPDATERAR SIN KLINISKA STRATEGI OCH BERÄKNADE MILSTOLPAR24.11.2020 08:00:00 CETPressemelding

Active Biotech AB (publ) (ticker: ACTI) meddelade idag statusuppdateringar av sina helägda projekt tasquinimod och laquinimod, liksom samarbetsprojektet naptumomab, utvecklat tillsammans med NeoTX Therapeutics. Investerare, analytiker och media är inbjudna till dagens virtuella kapitalmarknadsdag där den aktuella statusen och framtida utvecklingen av företagets kliniska portfölj och dess framtida strategi kommer att belysas. För ytterligare information, vänligen kontakta: Helén Tuvesson, VD, 046 19 21 56, helen@tuvesson@activebiotech.com Hans Kolam, CFO, 046 19 20 44, hans.kolam@activebiotech.com Denna information är sådan information som Active Biotech är skyldig att offentliggöra enligt EU:s marknadsmissbruksförordning. Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 24 november 2020 kl. 08.00. Om Active Biotech Active Biotech AB (publ) (Nasdaq Stockholm: ACTI) är ett bioteknikföretag som använder sin omfattande kompetensbas och projektportf

Ahold Delhaize share buyback update24.11.2020 08:00:00 CETPress release

Zaandam, the Netherlands, November 24, 2020 – Ahold Delhaize has repurchased 1,071,128 of Ahold Delhaize common shares in the period from November 16, 2020 up to and including November 20, 2020. The shares were repurchased at an average price of €23.39 per share for a total consideration of € 25.1 million. These repurchases were made as part of the €1 billion share buyback program announced on December 4, 2019. The total number of shares repurchased under this program to date is 41,012,539 common shares for a total consideration of € 943 million. Download the share buyback transactions excel sheet for detailed individual transaction information from www.aholddelhaize.com/en/investors/share-information/share-buy-back-programs/ This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs.

ACTIVE BIOTECH UPDATES ITS CLINICAL STRATEGY AND PROJECTED MILESTONES24.11.2020 08:00:00 CETPress release

Active Biotech AB (publ) (ticker: ACTI) today announced updates of its fully owned projects tasquinimod and laquinimod, as well the project naptumomab, developed in partnership with NeoTX Therapeutics. Investors, analysts and media are invited to today’s virtual Capital Markets Day where the current status and future developments of the company’s clinical portfolio and its future strategy will be highlighted. For further information, please contact: Helén Tuvesson, CEO, +46 46 19 21 56, helen@tuvesson@activebiotech.com Hans Kolam, CFO, +46 46 19 20 44, hans.kolam@activebiotech.com Active Biotech is obligated to make public the information contained in this report pursuant to the EU Market Abuse Regulation. This information was provided to the media, through the agency of the contact persons set out above, for publication November 24, 2020 at 08.00 CET. About Active Biotech Active Biotech AB (publ) (NASDAQ Stockholm: ACTI) is a biotechnology company that deploys its extensive knowledge

10kW+ Laser Cutting Machine Made a Sales Record of 260 Sets, Bodor Laser Constantly Surprises the Market24.11.2020 07:42:54 CETPress release

SHANDONG, China, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The spring of 2020 is different. A sudden epidemic has stopped us from all kinds of progress. The world is shrouded in the haze of the epidemic, and the COVID-19 epidemic has become a matter of concern to everyone. There is no doubt that the outbreak of this epidemic has brought a great blow to the world economy. In this context, “high efficiency” has become the overall demand of manufacturing and processing in several major industries such as heavy machinery, urban rail transit, high-speed rail and new energy etc. With its excellent performance, 10kW+ laser cutting machine has gradually become the darling of the market and has been adopted by the majority of metal processing enterprises. As one of the fastest-growing companies in the laser industry, Bodor Laser has also taken part in this activity. Bodor Laser's 10kW+ products have become a representative of new productivity in the field of laser cutting by virtue of wider and deeper

Klövern signs two new rental contracts in Copenhagen24.11.2020 07:30:00 CETPress release

Klövern has signed a contract with Parfums Christian Dior for 973 sq.m. office space and a contract with Politiforbundet for 1,946 sq.m. office space in the so-called Codan-house on Gammel Kongevej in Copenhagen. Moving-in is estimated to be on 1 March 2021 and 1 June 2021, respectively. ”It is with great pleasure that we welcome our new tenants to the Codan-house where we have had a very great interest in rentals after our acquisition of the property. The Copenhagen rental market is strong and these lettings are steps in our plan to transform the property from a single-tenant property to an attractive modern multi-let property”, says Andreas Lange, Head of Klövern’s business unit Copenhagen. Klövern AB (publ) For additional information, please contact: Rutger Arnhult, CEO, +46 (0)70-458 24 70, rutger.arnhult@klovern.se Lars Norrby, IR, +46 (0)76-777 38 00, lars.norrby@klovern.se Klövern is a real estate company committed to working closely with customers to offer them attractive premi

Klövern tecknar två nya hyresavtal i Köpenhamn24.11.2020 07:30:00 CETPressemelding

Klövern har tecknat ett avtal med Parfums Christian Dior avseende 973 kvm kontorsyta och ett avtal med Politiforbundet avseende 1 946 kvm kontorsyta i det så kallade Codan-huset på Gammel Kongevej i Köpenhamn. Inflyttning beräknas ske den 1 mars 2021 respektive 1 juni 2021. ”Det är med stor glädje vi välkomnar våra nya hyresgäster till Codan-huset där vi haft ett mycket stort intresse för förhyrningar efter vårt förvärv av fastigheten. Köpenhamns hyresmarknad är stark och dessa uthyrningar är ett led i vår plan att ställa om fastigheten från en single-tenant-fastighet till en attraktiv modern mutli-let-fastighet”, säger Andreas Lange, Klöverns affärsenhetschef i Köpenhamn. Klövern AB (publ) För ytterligare information, vänligen kontakta: Rutger Arnhult, VD, 070-458 24 70, rutger.arnhult@klovern.se Lars Norrby, IR, 076-777 38 00, lars.norrby@klovern.se Klövern är ett fastighetsbolag som med närhet och engagemang erbjuder attraktiva lokaler i tillväxtregioner. Klövern är noterad på Nasda